Ocular Therapeutix (OCUL) Insider Trading & Ownership $10.39 -0.14 (-1.33%) (As of 11/1/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ocular Therapeutix (NASDAQ:OCUL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$7.00 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$224,666.50 Get OCUL Insider Trade Alerts Want to know when executives and insiders are buying or selling Ocular Therapeutix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OCUL Insider Buying and Selling by Quarter Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. Ocular Therapeutix Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/23/2024Sanjay NayakInsiderSell1,832$9.02$16,524.64 5/23/2024Sanjay NayakInsiderSell2,274$5.84$13,280.16 2/26/2024Summer Road LlcMajor ShareholderBuy930,851$7.52$6,999,999.52 1/31/2024Antony C MattessichCEOSell18,338$4.95$90,773.10 1/31/2024Donald NotmanCFOSell6,433$4.95$31,843.35 1/31/2024Philip C StrassburgerGeneral CounselSell6,831$4.95$33,813.45 1/31/2024Rabia Gurses OzdenInsiderSell7,764$4.95$38,431.80 (Data available from 1/1/2013 forward) OCUL Insider Trading Activity - Frequently Asked Questions Who is on Ocular Therapeutix's Insider Roster? The list of insiders at Ocular Therapeutix includes Antony C Mattessich, Christopher G White, Donald Notman, Philip C Strassburger, Rabia Gurses Ozden, Sanjay Nayak, and Summer Road Llc. Learn more on insiders at OCUL. What percentage of Ocular Therapeutix stock is owned by insiders? 3.50% of Ocular Therapeutix stock is owned by insiders. Learn more on OCUL's insider holdings. Which Ocular Therapeutix insiders have been buying company stock? The following insiders have purchased OCUL shares in the last 24 months: Antony C Mattessich ($24,765.00), and Summer Road Llc ($7,025,647.52). How much insider buying is happening at Ocular Therapeutix? Insiders have purchased a total of 944,679 OCUL shares in the last 24 months for a total of $7,050,412.52 bought. Which Ocular Therapeutix insiders have been selling company stock? The following insiders have sold OCUL shares in the last 24 months: Antony C Mattessich ($174,169.66), Christopher G White ($24,714.96), Donald Notman ($59,301.59), Philip C Strassburger ($60,020.89), Rabia Gurses Ozden ($42,533.56), and Sanjay Nayak ($29,804.80). How much insider selling is happening at Ocular Therapeutix? Insiders have sold a total of 82,459 Ocular Therapeutix shares in the last 24 months for a total of $390,545.46 sold. Ocular Therapeutix Key ExecutivesMr. Donald Notman Jr.CFO, COO & Principal Accounting OfficerDr. Jeffrey S. Heier M.D. (Age 63)Chief Scientific Officer Compensation: $86.16kDr. Pravin U. Dugel M.D. (Age 60)Executive Chairman, President & CEO Dr. Peter K. Jarrett Ph.D. (Age 67)Chief Technology Officer Mr. William S. Slattery Jr.Vice President of Investor RelationsMr. William H. Ransone IIVice President of Global Sales & MarketingMs. Tracy SmithVice President of Human ResourcesMr. Steve MeyersChief Commercial OfficerDr. Peter K. Kaiser M.D.Chief Development OfficerMr. Sanjay Nayak MBBS (Age 54)Ph.D., Chief Strategy Officer More Insider Trading Tools from MarketBeat Related Companies SUPN Insider Trading KNSA Insider Trading INVA Insider Trading ARQT Insider Trading PHAT Insider Trading PLRX Insider Trading TBPH Insider Trading KPTI Insider Trading ELAN Insider Trading NUVL Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Big Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside This page (NASDAQ:OCUL) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocular Therapeutix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocular Therapeutix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
